Obstetrics & Gynecology Doctors in Rexburg, ID Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Bruce Clinton Barton, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 15 Madison Professional Park, Rexburg, ID 83440 Phone: 208-356-6185    Fax: 208-356-0378

Edward E Evans, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 15 Madison Professional Park, Rexburg, ID 83440 Phone: 208-356-6185    Fax: 208-356-0378

Dr. John Weston Allred, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 15 Madison Professional Park, Rexburg, ID 83440 Phone: 208-356-6185    Fax: 208-356-0378

Dr. Matthew Hardy Allred, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 15 Madison Professional Park, Rexburg, ID 83440 Phone: 208-356-6185    Fax: 208-356-0378

Dr. Cameron James Codd, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 37 S 2nd E, Rexburg, ID 83440 Phone: 208-356-0234    Fax: 208-656-0365

Dr. Robert E. Meredith, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 37 S 2nd E, Rexburg, ID 83440 Phone: 208-356-0234

News Archive

Fast-track genetic diagnosis for hearing loss

Over 28 million Americans are hearing impaired, and 50 percent of these cases can be traced to genetic causes. The condition can be especially challenging for children born hearing impaired because spoken language, reading, and cognitive development are tied to hearing. That makes early diagnosis essential for identifying appropriate therapy and treatment.

MD Anderson-led Phase III clinical study determines Sprycel superior to Gleevec as front-line therapy

Dasatanib, a medication currently approved as treatment for drug-resistant chronic myeloid leukemia, provided patients with quicker, better responses as a first therapy than the existing front-line drug, according to researchers at The University of Texas MD Anderson Cancer Center.

3 out of 20 GI endoscopes used for screening harbor unacceptable levels of "bio dirt"

Three out of 20 flexible gastrointestinal (GI) endoscopes used for screening were found to harbor unacceptable levels of "bio dirt" - cells and matter from a patient's body that could pose potential infection risk - according to a study of endoscopes used at five hospitals across the U.S.

Study reveals potential therapeutic targets for treating patients who carry IFNGR receptor mutation

The study began by taking the medical history of 11 children, all of whom had a disorder due to mycobacteria infections, as the basis. All were discovered to have the same phenotype with the same mutation, which was located in the interferon-gamma (IFNGR) receptor, so the group began to explore what was causing this dysfunction.

Read more Medical News

› Verified 9 days ago